Max Robotics — Global Service Robot Directory + US Certification

About

Mario Rietjens is a pioneering breast surgeon whose work has fundamentally reshaped the landscape of surgical oncology, particularly through the development and validation of robotic techniques for breast cancer treatment. His primary research focus lies in the intersection of oncologic safety and aesthetic preservation, specifically advancing robotic nipple-sparing mastectomy (R-NSM) and immediate breast reconstruction. Rietjens’ major contributions include demonstrating the feasibility and safety of this minimally invasive approach, as evidenced by his landmark 2016 study (178 citations) and a foundational 2015 paper (165 citations) detailing the technique. He further solidified this paradigm shift by leading a randomized trial (2021, 100 citations) that directly compared robotic mastectomy to open surgery, providing critical evidence on surgical outcomes and quality of life. With over 530 combined citations across his most influential works, Rietjens has established a robust evidence base for robotic breast surgery. His work not only reduces surgical morbidity but also improves cosmetic results, setting a new standard for patient-centered care in breast oncology.